Canopy Partners, LLC Astrazeneca PLC Transaction History
Canopy Partners, LLC
- $299 Billion
- Q3 2025
A detailed history of Canopy Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Canopy Partners, LLC holds 5,401 shares of AZN stock, worth $482,849. This represents 0.14% of its overall portfolio holdings.
Number of Shares
5,401
Previous 4,995
8.13%
Holding current value
$482,849
Previous $349 Million
18.71%
% of portfolio
0.14%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...